Nippon Shinyaku Co., Ltd. (4516):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Nippon Shinyaku Co., Ltd. (4516) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH31788FSA
◆発行会社(調査会社):GlobalData
◆発行日:2014年11月3日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Nippon Shinyaku Co., Ltd. (4516) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nippon Shinyaku Co., Ltd (Nippon) is a pharmaceutical company. It undertakes the development, manufacture and sale of ethical pharmaceuticals and foodstuffs. The company manufactures and sells a wide range of drugs including drugs for pain, inflammation, and allergies; drugs for urological diseases; drugs for hematologic malignancies; drugs for gastrointestinal disorders; drugs for cardiovascular and metabolic diseases; and others. Nippon develops, produces and sells functional food ingredients including health food ingredients, preservatives, spices and condiments, protein preparations, nutritional ingredients and others. Nippon operates its business through a network of offices in Japan, China, the UK and the US. Nippon is headquartered in Minami-ku, Kyoto, Japan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 – About the Company 6
Nippon Shinyaku Co., Ltd. – Key Facts 6
Nippon Shinyaku Co., Ltd. – Key Employees 7
Nippon Shinyaku Co., Ltd. – Key Operational Employees 8
Nippon Shinyaku Co., Ltd. – Major Products and Services 9
Nippon Shinyaku Co., Ltd. – Pharmaceutical Pipeline Products Data 10
Nippon Shinyaku Co., Ltd., Pipeline Products by Therapy Area 10
Nippon Shinyaku Co., Ltd., Pipeline Products by Development Phase 11
Nippon Shinyaku Co., Ltd. – History 13
Nippon Shinyaku Co., Ltd. – Company Statement 16
Nippon Shinyaku Co., Ltd. – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Section 2 – Company Analysis 20
Nippon Shinyaku Co., Ltd. – Business Description 20
Nippon Shinyaku Co., Ltd. – Corporate Strategy 21
Nippon Shinyaku Co., Ltd. – SWOT Analysis 22
SWOT Analysis – Overview 22
Nippon Shinyaku Co., Ltd. – Strengths 22
Strength – Sturdy Research And Development Activities 22
Strength – Product Portfolio 22
Strength – Robust Financial Performance 22
Nippon Shinyaku Co., Ltd. – Weaknesses 23
Weakness – High Trade Receivables 23
Nippon Shinyaku Co., Ltd. – Opportunities 24
Opportunity – New Product Launches 24
Opportunity – Strategic Agreements 24
Opportunity – Orphan Drug Designation 24
Nippon Shinyaku Co., Ltd. – Threats 25
Threat – Changes in the Regulations 25
Threat – Safety Regulations for Functional Foods 25
Threat – Uncertainties in R&D 25
Nippon Shinyaku Co., Ltd. – Key Competitors 26
Section 3 – Company Financial Ratios 27
Financial Ratios – Capital Market Ratios 27
Financial Ratios – Annual Ratios 28
Performance Chart 29
Financial Performance 29
Financial Ratios – Interim Ratios 30
Financial Ratios – Ratio Charts 31
Section 4 – Company’s Lifesciences Financial Deals and Alliances 32
Nippon Shinyaku Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 32
Nippon Shinyaku Co., Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 33
Nippon Shinyaku Co., Ltd., Recent Deals Summary 34
Section 5 – Appendix 35
Methodology 35
Ratio Definitions 35
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Nippon Shinyaku Co., Ltd., Key Facts 6
Nippon Shinyaku Co., Ltd., Key Employees 7
Nippon Shinyaku Co., Ltd., Key Operational Employees 8
Nippon Shinyaku Co., Ltd., Major Products and Services 9
Nippon Shinyaku Co., Ltd., Number of Pipeline Products by Therapy Area 10
Nippon Shinyaku Co., Ltd., Number of Pipeline Products by Development Stage 11
Nippon Shinyaku Co., Ltd., Pipeline Products By Therapy Area and Development Phase 12
Nippon Shinyaku Co., Ltd., History 13
Nippon Shinyaku Co., Ltd., Other Locations 17
Nippon Shinyaku Co., Ltd., Subsidiaries 19
Nippon Shinyaku Co., Ltd., Key Competitors 26
Nippon Shinyaku Co., Ltd., Ratios based on current share price 27
Nippon Shinyaku Co., Ltd., Annual Ratios 28
Nippon Shinyaku Co., Ltd., Interim Ratios 30
Nippon Shinyaku Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 32
Nippon Shinyaku Co., Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 33
Nippon Shinyaku Co., Ltd., Recent Deals Summary 34
Currency Codes 35
Capital Market Ratios 35
Equity Ratios 36
Profitability Ratios 36
Cost Ratios 37
Liquidity Ratios 37
Leverage Ratios 38
Efficiency Ratios 38

List of Figures
Nippon Shinyaku Co., Ltd., Pipeline Products by Therapy Area 10
Nippon Shinyaku Co., Ltd., Pipeline Products by Development Phase 11
Nippon Shinyaku Co., Ltd., Performance Chart (2010 - 2014) 29
Nippon Shinyaku Co., Ltd., Ratio Charts 31
Nippon Shinyaku Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 32
Nippon Shinyaku Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 33

★調査レポート[Nippon Shinyaku Co., Ltd. (4516):企業概要、財務及び戦略的SWOT分析] (コード:GDPH31788FSA)販売に関する免責事項を必ずご確認ください。
★調査レポート[Nippon Shinyaku Co., Ltd. (4516):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆